• Menu
  • Skip to right header navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Before Header

  • Axis Clinicals USA

Axis Clinicals

Contract Research Organization

  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice โ€“ WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report
    • Codes & Policies
      • 1. Vigil Mechanism Policy
      • 2. Corporate Social Responsibility Policy
      • 3. Criteria for Directors
      • 4. Nomination & Remuneration Policy
    • Corporate Social Responsibility
      • 1. Corporate Social Responsibility Policy
      • 2. Composition of CSR Committee
    • Annual Return
      • 1. FY 2020-21
      • 2. FY 2021-22
      • 3. FY 2022-23
  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice โ€“ WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report
    • Codes & Policies
      • 1. Vigil Mechanism Policy
      • 2. Corporate Social Responsibility Policy
      • 3. Criteria for Directors
      • 4. Nomination & Remuneration Policy
    • Corporate Social Responsibility
      • 1. Corporate Social Responsibility Policy
      • 2. Composition of CSR Committee
    • Annual Return
      • 1. FY 2020-21
      • 2. FY 2021-22
      • 3. FY 2022-23

Phase II-IV

You are here: Home / Phase II-IV

Our integrated capabilities can help you minimize risk, ensure trial feasibility and drive regulatory and commercial success of your program.

Our team of clinical research professionals are efficient in designing the protocol, conducting the study, generation of the clinical study report and the regulatory submissions. Our well-trained and highly qualified Project Managers, Senior Clinical Research Associates, Clinical Research Associates and Clinical Trial Assistants having years of clinical monitoring experience across various therapeutic areas are working with more than 200 clinical investigators across 110 research sites to execute the projects.

AXIS Clinicals offers a full range of clinical research services for the pharmaceutical, medical device, biopharmaceutical and CRO industries including:

  • Study Development
  • Site Qualification visit
  • Site Initiation visit
  • Interim monitoring visit
  • Site Close out visit
  • Intellectual Advisory Board
  • Translational Science Specialists
  • Protocol Development
  • CRF Design & Distribution
  • Patient Recruitment

Additionally, we have the proven track record to conduct New Drug Application (NDA) and Biologics License Application (BLA) clinical studies across range of therapeutic areas for vast study types with diverse healthy volunteers and patient population.

Primary Sidebar

Menu

  • Home
  • About Us
    • Our DNA
    • Our Core Values
    • Your Preferred Partner of Choice โ€“ WHY?
    • Our Focus
    • Our Leadership
    • Accreditations
    • Global Locations
  • Services
    • BA | BE Studies
    • PK | PD and Patient Studies
    • Bio-Analytical Services
    • Phase I
    • Phase II-IV
    • Project Management
    • PK | Biostatistics & Programming
    • Medical Writing
    • Regulatory Services
    • Quality Assurance and Compliance
    • Clinical Data Management
    • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us
  • Investors
    • Annual Report
    • Codes & Policies
      • 1. Vigil Mechanism Policy
      • 2. Corporate Social Responsibility Policy
      • 3. Criteria for Directors
      • 4. Nomination & Remuneration Policy
    • Corporate Social Responsibility
      • 1. Corporate Social Responsibility Policy
      • 2. Composition of CSR Committee
    • Annual Return
      • 1. FY 2020-21
      • 2. FY 2021-22
      • 3. FY 2022-23

Footer

  • About Us
  • Our DNA
  • Our Core Values
  • Your Preferred Partner of Choice
  • Our Focus
  • Our Leadership
  • Accreditations
  • Global Locations
  • Services
  • BA | BE Studies
  • PK | PD and Patient Studies
  • Bio-Analytical Services
  • Phase II-IV
  • Project Management
  • PK | Biostatistics & Programming
  • Medical Writing
  • Regulatory Services
  • Quality Assurance and Compliance
  • Clinical Data Management
  • Clinical Central Lab
  • Careers
  • News & Media
  • Contact Us

Copyright © 2025 ยท Axis Clinicals